Bio-Techne Corp (STU:TE1)
€ 69.5 0 (0%) Market Cap: 11.07 Bil Enterprise Value: 11.27 Bil PE Ratio: 80.74 PB Ratio: 5.63 GF Score: 95/100

Bio-Techne Corp at Leerink Global Healthcare Conference Transcript

Feb 26, 2020 / 04:30PM GMT
Release Date Price: €46 (+1.66%)
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst

Jim, the first question that I have here -- and let's talk a little bit about the quarter.

Questions & Answers

Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst

You've traditionally grown about 10% to 12%. You maintained your guide there. Maybe just give us -- provide a bit of a backdrop of what happened in the quarter, onetime items. Are some of those things -- do you expect some of those to continue into the next couple of quarters here? And how should we think about the 10% to 12% for this year?

James T. Hippel
Bio-Techne Corporation - Senior VP of Finance & CFO

So yes, so Q2 was a lower quarter for us organic growth-wise and -- than what we've been accustomed to seeing. It was really -- a lot of it is driven out of Europe. Europe was -- it was down actually year-over-year for us, which has been double-digit

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot